UnitedHealth Group Incorporated – Consensus Indicates Potential 9.1% Upside

DirectorsTalk Interviews

UnitedHealth Group Incorporated with ticker code (UNH) have now 24 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 632 and 360 and has a mean target at 573.79. Given that the stocks previous close was at 525.86 this now indicates there is a potential upside of 9.1%. There is a 50 day moving average of 528.68 and the 200 day MA is 498.92. The market cap for the company is $493,424m. Visit the company website at: https://www.unitedhealthgroup.com

The potential market cap would be $538,397m based on the market concensus.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

Share on:

Latest Company News

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its SIRT6 patent portfolio.

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

Real Estate Credit Investments maintained its 3p quarterly dividend, offering a 10.3% yield, while outlining routes to restore dividend cover. Credit performance remains strong, leverage is conservative and the shares continue to trade at a substantial discount to NAV.

RM Assessment targets expanding demand for digital exams

RM Assessment is positioned to benefit as schools and awarding bodies adopt more digital and hybrid examination systems.

Drax takes control of Aldi’s UK EV charging network

Drax will operate and expand around 1,200 electric vehicle chargers across Aldi’s UK store network.

Energy strength and resilient trading updates support the FTSE 100

Higher oil prices and resilient company updates supported a steadier outlook for the FTSE 100.

AI leadership gives emerging markets a stronger strategic position

Emerging markets are gaining a more important role in the global artificial intelligence economy, led by major Asian semiconductor companies with strong positions in advanced computing infrastructure.

    Search